Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...
Some 30% to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure. To mark ...
A new ketamine pill may help hard-to-treat depression with fewer side effects than other forms of the treatment, early research suggests. Technically, no form of ketamine has been approved by the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback